APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pathology Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pathology Software Market Outlook and Growth Opportunities 2026

Report ID 174450450412 August 2026190 pages

Choose your research edition.

Industry ResearchPathology Software Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pathology Software Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Pathology Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pathology Software Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pathology Software Market Analysis and Forecast 2026-2032171 pages · $4,950 USD

Market perspective

The global Pathology Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pathology Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pathology Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pathology Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pathology Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pathology Software market include LBP, F. Q. Pathotech, CellsVision, Sectra, Digital Slide Archive, Aiforia, PathAI, Pathomation and Proscia, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pathology Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pathology Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pathology Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pathology Software market.

Pathology Software Segment by Company

LBP

F. Q. Pathotech

CellsVision

Sectra

Digital Slide Archive

Aiforia

PathAI

Pathomation

Proscia

Indica Labs

Gestalt

Hologic

Dipath

iDeepWise

Pathology Software Segment by Type

LIS

IIMS

AI Separated

Pathology Software Segment by Application

Hospital

Diagnostic Centers

R&D Lab

Pathology Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pathology Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pathology Software key companies, revenue, market share, and recent developments.

3. To split the Pathology Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pathology Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pathology Software significant trends, drivers, influence factors in global and regions.

6. To analyze Pathology Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathology Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pathology Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathology Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pathology Software industry.

Chapter 3: Detailed analysis of Pathology Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pathology Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pathology Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pathology Software Industry Trends Table 2. Pathology Software Industry Drivers Table 3. Pathology Software Industry Opportunities and Challenges Table 4. Pathology Software Industry Restraints Table 5. Global Pathology Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pathology Software Revenue Share by Company (2021-2026) Table 7. Global Pathology Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pathology Software Key Company Manufacturing Base & Headquarters Table 9. Global Pathology Software Company, Product Type & Application Table 10. Global Pathology Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pathology Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of LIS Table 15. Significant Companies of IIMS Table 16. Significant Companies of AI Separated Table 17. Global Pathology Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Pathology Software Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Pathology Software Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Pathology Software Sales Value Share by Type (2021-2026) Table 21. Global Pathology Software Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Table 23. Significant Companies of Diagnostic Centers Table 24. Significant Companies of R&D Lab Table 25. Global Pathology Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pathology Software Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Pathology Software Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Pathology Software Sales Value Share by Application (2021-2026) Table 29. Global Pathology Software Sales Value Share by Application (2027-2032) Table 30. Global Pathology Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pathology Software Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Pathology Software Sales Value Share by Region (2021-2026) Table 33. Global Pathology Software Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Pathology Software Sales Value Share by Region (2027-2032) Table 35. Global Pathology Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Pathology Software Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Pathology Software Sales Value Market Share by Country (2021-2026) Table 38. Global Pathology Software Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Pathology Software Sales Value Market Share by Country (2027-2032) Table 40. LBP Company Information Table 41. LBP Business Overview Table 42. LBP Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. LBP Pathology Software Product Portfolio Table 44. LBP Recent Development Table 45. F. Q. Pathotech Company Information Table 46. F. Q. Pathotech Business Overview Table 47. F. Q. Pathotech Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. F. Q. Pathotech Pathology Software Product Portfolio Table 49. F. Q. Pathotech Recent Development Table 50. CellsVision Company Information Table 51. CellsVision Business Overview Table 52. CellsVision Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. CellsVision Pathology Software Product Portfolio Table 54. CellsVision Recent Development Table 55. Sectra Company Information Table 56. Sectra Business Overview Table 57. Sectra Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Sectra Pathology Software Product Portfolio Table 59. Sectra Recent Development Table 60. Digital Slide Archive Company Information Table 61. Digital Slide Archive Business Overview Table 62. Digital Slide Archive Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Digital Slide Archive Pathology Software Product Portfolio Table 64. Digital Slide Archive Recent Development Table 65. Aiforia Company Information Table 66. Aiforia Business Overview Table 67. Aiforia Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Aiforia Pathology Software Product Portfolio Table 69. Aiforia Recent Development Table 70. PathAI Company Information Table 71. PathAI Business Overview Table 72. PathAI Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. PathAI Pathology Software Product Portfolio Table 74. PathAI Recent Development Table 75. Pathomation Company Information Table 76. Pathomation Business Overview Table 77. Pathomation Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Pathomation Pathology Software Product Portfolio Table 79. Pathomation Recent Development Table 80. Proscia Company Information Table 81. Proscia Business Overview Table 82. Proscia Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Proscia Pathology Software Product Portfolio Table 84. Proscia Recent Development Table 85. Indica Labs Company Information Table 86. Indica Labs Business Overview Table 87. Indica Labs Pathology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Indica Labs Pathology Software Product Portfolio Table 89. Indica Labs Recent Development Table 90. Gestalt Company Information Table 91. Gestalt Business Overview Table 92. Gestalt Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Gestalt Pathology Software Product Portfolio Table 94. Gestalt Recent Development Table 95. Hologic Company Information Table 96. Hologic Business Overview Table 97. Hologic Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Hologic Pathology Software Product Portfolio Table 99. Hologic Recent Development Table 100. Dipath Company Information Table 101. Dipath Business Overview Table 102. Dipath Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Dipath Pathology Software Product Portfolio Table 104. Dipath Recent Development Table 105. iDeepWise Company Information Table 106. iDeepWise Business Overview Table 107. iDeepWise Pathology Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. iDeepWise Pathology Software Product Portfolio Table 109. iDeepWise Recent Development Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Pathology Software Product Image Figure 2. Global Pathology Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pathology Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Pathology Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. LIS Image Figure 8. IIMS Image Figure 9. AI Separated Image Figure 10. Global Pathology Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Pathology Software Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Pathology Software Sales Value Share by Type (2021-2032) Figure 13. Hospital Image Figure 14. Diagnostic Centers Image Figure 15. R&D Lab Image Figure 16. Global Pathology Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pathology Software Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pathology Software Sales Value Share by Application (2021-2032) Figure 19. Global Pathology Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Pathology Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Pathology Software Sales Value (2021-2032) & (US$ Million) Figure 22. North America Pathology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Pathology Software Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Pathology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Pathology Software Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Pathology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Pathology Software Sales Value (2021-2032) & (US$ Million) Figure 28. South America Pathology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Pathology Software Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Pathology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Pathology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Pathology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Pathology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • LIS
  • IIMS
  • AI Separated
Applications
  • Hospital
  • Diagnostic Centers
  • R&D Lab
Companies covered
  • LBP
  • F. Q. Pathotech
  • CellsVision
  • Sectra
  • Digital Slide Archive
  • Aiforia
  • PathAI
  • Pathomation
  • Proscia
  • Indica Labs
  • Gestalt
  • Hologic
  • Dipath
  • iDeepWise

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pathology Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pathology Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pathology Software Market Dynamics
  1. 2.1 Pathology Software Industry Trends
  2. 2.2 Pathology Software Industry Drivers
  3. 2.3 Pathology Software Industry Opportunities and Challenges
  4. 2.4 Pathology Software Industry Restraints
3 Pathology Software Market by Company
  1. 3.1 Global Pathology Software Company Revenue Ranking in 2025
  2. 3.2 Global Pathology Software Revenue by Company (2021-2026)
  3. 3.3 Global Pathology Software Company Ranking (2024-2026)
  4. 3.4 Global Pathology Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Pathology Software Company Product Type and Application
  6. 3.6 Global Pathology Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pathology Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pathology Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pathology Software Market by Type
  1. 4.1 Pathology Software Type Introduction
  2. 4.1.1 LIS
  3. 4.1.2 IIMS
  4. 4.1.3 AI Separated
  5. 4.2 Global Pathology Software Sales Value by Type
  6. 4.2.1 Global Pathology Software Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pathology Software Sales Value by Type (2021-2032)
  8. 4.2.3 Global Pathology Software Sales Value Share by Type (2021-2032)
5 Pathology Software Market by Application
  1. 5.1 Pathology Software Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Diagnostic Centers
  4. 5.1.3 R&D Lab
  5. 5.2 Global Pathology Software Sales Value by Application
  6. 5.2.1 Global Pathology Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pathology Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pathology Software Sales Value Share by Application (2021-2032)
6 Pathology Software Regional Value Analysis
  1. 6.1 Global Pathology Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pathology Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pathology Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pathology Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pathology Software Sales Value (2021-2032)
  7. 6.3.2 North America Pathology Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pathology Software Sales Value (2021-2032)
  10. 6.4.2 Europe Pathology Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pathology Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pathology Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pathology Software Sales Value (2021-2032)
  16. 6.6.2 South America Pathology Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pathology Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pathology Software Sales Value Share by Country, 2025 VS 2032
7 Pathology Software Country-level Value Analysis
  1. 7.1 Global Pathology Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pathology Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pathology Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pathology Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pathology Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pathology Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pathology Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pathology Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pathology Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pathology Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pathology Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pathology Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pathology Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pathology Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pathology Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pathology Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pathology Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pathology Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pathology Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pathology Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pathology Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pathology Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pathology Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pathology Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pathology Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pathology Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pathology Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pathology Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pathology Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pathology Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pathology Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pathology Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pathology Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pathology Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pathology Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pathology Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pathology Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pathology Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pathology Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pathology Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pathology Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pathology Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pathology Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pathology Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pathology Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pathology Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pathology Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pathology Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pathology Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pathology Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pathology Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pathology Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pathology Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pathology Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pathology Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pathology Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pathology Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pathology Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pathology Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pathology Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pathology Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pathology Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pathology Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pathology Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pathology Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pathology Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pathology Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pathology Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pathology Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pathology Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pathology Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pathology Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pathology Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pathology Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pathology Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pathology Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pathology Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pathology Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pathology Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pathology Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pathology Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pathology Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pathology Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pathology Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pathology Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pathology Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pathology Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pathology Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 LBP
  2. 8.1.1 LBP Company Information
  3. 8.1.2 LBP Business Overview
  4. 8.1.3 LBP Pathology Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 LBP Pathology Software Product Portfolio
  6. 8.1.5 LBP Recent Developments
  7. 8.2 F. Q. Pathotech
  8. 8.2.1 F. Q. Pathotech Company Information
  9. 8.2.2 F. Q. Pathotech Business Overview
  10. 8.2.3 F. Q. Pathotech Pathology Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 F. Q. Pathotech Pathology Software Product Portfolio
  12. 8.2.5 F. Q. Pathotech Recent Developments
  13. 8.3 CellsVision
  14. 8.3.1 CellsVision Company Information
  15. 8.3.2 CellsVision Business Overview
  16. 8.3.3 CellsVision Pathology Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CellsVision Pathology Software Product Portfolio
  18. 8.3.5 CellsVision Recent Developments
  19. 8.4 Sectra
  20. 8.4.1 Sectra Company Information
  21. 8.4.2 Sectra Business Overview
  22. 8.4.3 Sectra Pathology Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sectra Pathology Software Product Portfolio
  24. 8.4.5 Sectra Recent Developments
  25. 8.5 Digital Slide Archive
  26. 8.5.1 Digital Slide Archive Company Information
  27. 8.5.2 Digital Slide Archive Business Overview
  28. 8.5.3 Digital Slide Archive Pathology Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Digital Slide Archive Pathology Software Product Portfolio
  30. 8.5.5 Digital Slide Archive Recent Developments
  31. 8.6 Aiforia
  32. 8.6.1 Aiforia Company Information
  33. 8.6.2 Aiforia Business Overview
  34. 8.6.3 Aiforia Pathology Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Aiforia Pathology Software Product Portfolio
  36. 8.6.5 Aiforia Recent Developments
  37. 8.7 PathAI
  38. 8.7.1 PathAI Company Information
  39. 8.7.2 PathAI Business Overview
  40. 8.7.3 PathAI Pathology Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PathAI Pathology Software Product Portfolio
  42. 8.7.5 PathAI Recent Developments
  43. 8.8 Pathomation
  44. 8.8.1 Pathomation Company Information
  45. 8.8.2 Pathomation Business Overview
  46. 8.8.3 Pathomation Pathology Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pathomation Pathology Software Product Portfolio
  48. 8.8.5 Pathomation Recent Developments
  49. 8.9 Proscia
  50. 8.9.1 Proscia Company Information
  51. 8.9.2 Proscia Business Overview
  52. 8.9.3 Proscia Pathology Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Proscia Pathology Software Product Portfolio
  54. 8.9.5 Proscia Recent Developments
  55. 8.10 Indica Labs
  56. 8.10.1 Indica Labs Company Information
  57. 8.10.2 Indica Labs Business Overview
  58. 8.10.3 Indica Labs Pathology Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Indica Labs Pathology Software Product Portfolio
  60. 8.10.5 Indica Labs Recent Developments
  61. 8.11 Gestalt
  62. 8.11.1 Gestalt Company Information
  63. 8.11.2 Gestalt Business Overview
  64. 8.11.3 Gestalt Pathology Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Gestalt Pathology Software Product Portfolio
  66. 8.11.5 Gestalt Recent Developments
  67. 8.12 Hologic
  68. 8.12.1 Hologic Company Information
  69. 8.12.2 Hologic Business Overview
  70. 8.12.3 Hologic Pathology Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hologic Pathology Software Product Portfolio
  72. 8.12.5 Hologic Recent Developments
  73. 8.13 Dipath
  74. 8.13.1 Dipath Company Information
  75. 8.13.2 Dipath Business Overview
  76. 8.13.3 Dipath Pathology Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Dipath Pathology Software Product Portfolio
  78. 8.13.5 Dipath Recent Developments
  79. 8.14 iDeepWise
  80. 8.14.1 iDeepWise Company Information
  81. 8.14.2 iDeepWise Business Overview
  82. 8.14.3 iDeepWise Pathology Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 iDeepWise Pathology Software Product Portfolio
  84. 8.14.5 iDeepWise Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst